The chemical synthesis of backbone deuterium labelled [r(CGCGAAU*lTCGCG)] 2 (U* = [S'-W) is described. An efficient purification procedure was developed using a polymeric reverse phase (PRP) HPLC column at 60°C. This procedure provided pure RNA dodecamer In the multi-milligram quantities (39% overall yield) necessary for dynamics studies using solid-state deuterium NMR. The purification method has been effectively applied to other RNA sequences and will assist biophysical studies which require relatively large quantities of RNA oligomers.
INTRODUCTION
Solid-state deuterium NMR analysis of specifically deuterium labelled oligodeoxynucleotides has provided details about the amplitude and time-scale of internal motions in well defined regions of the biopolymer 1 " 3 . This information is of particular relevance in light of recent solution NMR/molecular dynamics studies on DNA 4 ' 5 where it has been claimed that local motions can significantly affect the NOE buildup rates between proton pairs. As more solution structural work is done on RNA oligomers 6 " 13 it will be necessary to understand and quantify the internal local motions in these systems. This information will be important not only from a dynamics standpoint but also for the correct interpretation of NOE data for structural studies.
Since solid-state deuterium NMR analysis requires relatively large amounts of material, typically > 30 mg, the RNA synthesis and purification need to be reasonably efficient. Chemical synthesis of short RNA oligomers is not as efficient as DNA synthesis due to the presence of the 2'-protecting group but has been optimized by Ogilvie and coworkers 14 . In contrast, the published procedures for purification and recovery of RNA oligomers have been laborious 15 or not very efficient 16 . This paper describes the synthesis of a [5'-2 H]-labelled uridine phosphoramidite and its incorporation at positions 7 and 8 in the solid-phase phosphite triester synthesis of [r(CGCG-AAUUCGCG)] 2 -In addition, an improved procedure for purifying the dodecamer, and RNA oligomers in general, using a reverse phase HPLC method is described.
MATERIALS AND METHODS
Oxalyl chloride, triethylamine, sodium borodeuteride, 4,4-dimethoxytrityl chloride, t-butyldimethylsilyl chloride, 1 M tetrabutylammonium fluoride in THF, 2-cyanoethyl N, Ndiisopropylchlorophosphoramidite, and N, A^-diisopropylethylamine were purchased from Aldrich Chemical Company. Pyridine and dichloromethane were refluxed from calcium hydride for 2-4 h and then distilled under nitrogen before use in reactions. All reactions were carried out under an atmosphere of dry nitrogen. Anhydrous methanolic ammonia (2 M) was purchased from Aldrich and ammonia was bubbled through the solution for 15-20 minutes before use.
Silica gel 60 (230-400 mesh) from E.M.Science was used for column chromatography. The thin-layer chromatograms were performed on precoated plates of silica gel (60-F254, aluminium support, E.M.Science) and spots made visible by UV detection and/or with 5% sulfuric acid in ethanol containing 1 % vanillin. Trimethylamine was purchased from J.T.Baker and HPLC grade acetonitrile (Omnisolve) was purchased from E.M.Science. Stock trimethylammonium acetate (1 M) was prepared by slowly adding trimethylamine (253 mL, 25 wt. % in water) to an ice-cold solution of glacial acetic acid/water (56/691, v/v). Purified water was obtained from a Nanopure system (Barnstead).
All NMR spectra were recorded at 300 K on a Bruker AMX-500 spectrometer using a 5 mm 'H selective probe. 'H NMR spectra of synthetic intermediates were recorded in CDC1 3 , CD3OD, or D2O as indicated. Chemical shifts were referenced to internal tetramethylsilane or sodium 2, 2-dimethyl-2-silapentane-5-sulfonate (DSS). Spectra of RNA oligomers were collected in phosphate buffer as indicated in the figure legends and processed using FTNMR/FELIX (Hare Research Inc., Bothell, WA).
Synthesis of 2',3'-0-isopropylidene-5'-oxouridlne 2
This compound was prepared using the method of Orban and Reid 17 . A solution of DMSO (1.84 mL, 7.2 mmol) in dichloromethane (6.4 mL) was added to a stirred solution of oxalyl chloride (1.24 mL, 14.3 mmol, 1.1 eq.) in dichloromethane (32 mL) at -78°C (dry ice/acetone) under nitrogen. After 3 minutes, a solution of 2',3'-0-isopropylideneuridine (3.68 g, 13 mmol) in DMSO/dichJoromethane
• To whom correspondence should be addressed (4.8mL/14.8mL) was added over a 5 minute period. Stirring was continued for 15 minutes, then triethylamine (9.2 mL, 64.8 mmol) was added and the reaction mixture was stirred for another 5 minutes. Trifluoroacetic acid (6.1 mL, 80 mmol, 6.0 eq.) was added and the mixture was allowed to warm to room temperature. The mixture was evaporated in vacua and the residue was lyophilized and used directly in the reduction step. Analysis by TLC (dichloromethane/hexane/ethyl acetate/ethyl alcohol, 10/5/5/1 v/v) showed the aldehyde (R f 0.6) as the major UVactive component with no residual alcohol (R f 0.5).
The crude residue from the oxidation procedure was suspended in water (120 mL) and cooled in an ice bath under nitrogen 17 . Sodium borodeuteride (1.92 g, 46 mmol) was added in portions over a period of 5 minutes and the mixture was allowed to warm to 25 C C with stirring. TLC analysis after 1 h showed total consumption of the aldehyde. Acetone (8 mL) was added and the solution was adjusted to pH -6.0 with 1 M HC1. The aqueous reaction mixture was lyophilized. The lyophilized powder was then partitioned between ethyl acetate (200 mL) and water (20 mL) and extracted two more times with ethyl acetate (200 mL each). The ethyl acetate layer was dried (N^SC^), filtered and concentrated to give a pale yellow syrup. Chromatography on a silica gel column (25x250 mm) using dichloromethane/methanol (98-92/2-8%, v/v) gave 2.17 g pure product for a 59% overall yield from the aldehyde. TLC analysis (dichloromethane/hexane/ethyl acetate/ethanol 10/5/5/1) showed that the deuterium labelled product (R f 0.5) was the major UVactive component with no residual aldehyde (R f 0.6).
• 
Synthesis of S'-O-dimethoxvtrityHS'-^-uridine 5 [5'-
2 H]-Uridine 4 (1.26 g, 5.16 mmol) was dissolved in dry pyridine (2.0 mL) and then evaporated to dryness in vacuo. This procedure was repeated twice before the residue was dissolved in dry pyridine (9 mL) and dimethoxytrityl chloride (1.79 g, 5.30 mmol) was added to the reaction mixture 19 . The mixture was stirred under nitrogen for 14 h and then poured into 100 mL of ice-water with rapid stirring. The precipitate was collected on a sintered funnel, washed with 10 mL of ice-water, dried and then dissolved in dichloromethane (100 mL) containing a drop of pyridine. The organic layer was dried with sodium sulfate and concentrated.The yellow residue was dissolved in dichloromethane (10 mL) and the solution was chromatographed on a column (2.5 x 30 cm) of silica gel. The column was washed with three bed volumes of dichloromethane and then dichloromethane/methanol (97/3, v/v) to elute the product 5. The total yield after chromatography was 2.42 g (86% 14 . After 4 h, TLC (dichloromethane/hexane/ethyl acetate/ethanol 10/5/5/1) indicated incomplete reaction (2'-silyl isomer R f 0.7; 3'-silyl isomer R f 0.5; 5'-DMTuridine R f 0.2). More silver nitrate (73 mg, O.leq) and t-butyldimethylsilyl chloride (65 mg, 0.1 eq) were added. After stirring 21 h, the mixture was filtered into 5% aqueous NaHCO 3 (50 mL). This was extracted with dichloromethane (2 x60 mL) and the combined organic extracts were dried with sodium sulfate. The solution was co-evaporated with toluene (2x50 mL) to remove pyridine and then purified by flash chromatography (2.5x30 cm size column) using 5% diethyl ether/dichloromethane to yield the 2'-silyl isomer 6 (2.11 g, 74%). Further elution with 5% methanol/dichloromethane gave pure fractions of the 3'-silyl isomer (0.5 g, 17%). The 2'-silyl isomer 6 was compared with commercially available 2'-tbutyldimethylsilyl-5'-dimethoxytrityluridine (Peninsula Laboratories) and found to be identical by TLC and 'H NMR with the exception of the 5' resonances.
•H NMR (CDCI3): 
Synthesis of 2'-
2 H]-uridine 6 (1.26 g, 1.90 mmol) was dissolved in dichloromethane (6.5 mL) and diisopropylethylamine (991 /*L, 3 eq.) preflushed with nitrogen. 2-Cyanoethyl N, N-diisopropylchlorophosphoramidite (638 /iL, 1.5 eq.) was added dropwise and the reaction mixture was stirred for 1 h at room temperature 15 . More chlorophosphoramidite (36 fiL, 0.2 eq.) was added and the reaction stirred for another 1 h. The reaction mixture was diluted with 50 mL of dichloromethane and extracted with 20 mL of an aqueous, saturated NaHCC>3 solution. The aqueous layer was further extracted with dichloromethane (2x50 mL). The combined organic solution was dried over anhydrous sodium sulfate and evaporated in vacua to a yellow syrup. The crude product was purified by flash chromatography (2.5 X30 cm size column) using ethyl acetate/hexane (3/2, v/v). The combined pure fractions were evaporated to give a colorless powder in quantitative yields. Before use in RNA synthesis, the phosphoramidite was dissolved in benzene, filtered through a glass-wool plug, and freeze-dried. This procedure was repeated twice to provide a colorless dry powder. The deuterium labelled phosphoramidite 7 was consistent with the corresponding commercially available phosphoramidite (BioGenex/ABN) by TLC and 'H NMR. The following nmr data are for the mixture of diastereoisomers. Assignments were determined from a magnitude COSY spectrum. ' 14 and N-benzoyl protected cytidine. Typical loading of the wide pore silica support was -25 micromoles/g. Syntheses were conducted on the 10 micromole scale using a standard ABI synthesis cycle with 0.1 M phosphoramidite solutions in acetonitrile and 7.5 equivalents of phosphoramidite per coupling step. Each coupling reaction was allowed to take place for 10 minutes. After completion of automated synthesis, the support was suspended in anhydrous methanolic ammonia (15 mL, room temperature, 24 h) to cleave the RNA from the support as well as remove phenoxyacetyl and cyanoethyl protecting groups. After the sample was centrifuged and decanted, solvent was evaporated under a stream of nitrogen. The residue was placed under high vacuum briefly to remove traces of solvent. The 2'-t-butyldimethylsilyl protecting groups were cleaved with 1 M tetrabutylammonium fluoride in THF (2 mL, room temperature, 18 h) and the solvent was evaporated under a stream of nitrogen followed by high vacuum. Tetrabutylammonium salts were removed on a 50W-X2 ion exchange column (sodium form, biotechnology grade, Bio-Rad). Fractions containing RNA eluted just after the void volume and were pooled and lyophilized. The crude RNA sample was purified using the preparative HPLC conditions outlined below.
HPLC Purification
HPLC purification was carried out on a Waters HPLC 820 Maxima System equipped with a dual wavelength Waters 490 UV/Vis detector (280 nm and 254 nm). A Hamilton Polypore PRP-1 column (350x7 mm) was used for both analytical and preparative runs. The column was heated at 60°C (Waters Column heater) with a flow rate of 3 mL/min. The system was operated using a linear gradient of 2-8% acetonitrile in aqueous trimethylammonium acetate buffer (0.1 M, pH 7.0) over a 40 minute period with a loading of approximately 2 micromoles RNA per injection. Purified samples were subsequently checked by analytical HPLC. Trace metal contaminants were removed by passing the HPLC-purified sample through a short column (2X1 cm) of Chelex 100 (sodium form, Bio-Rad).
RESULTS AND DISCUSSION

Synthesis of the [S'-^l-Uridine Phosphoramfdite 7
The synthesis of [5'-2 H]-labelled phosphoramidite 7 is summarized in Scheme 1.2', 3'-O-Isopropylideneuridine 1 was oxidized to the aldehyde 2 using a modified Swern procedure 17 . Attempts to purify the aldehyde resulted in substantial oxidation and therefore the crude aldehyde was reduced directly with sodium borodeuteride to provide [5'-2 H]-2', 3'-Oisopropylideneuridine 3 in 59% overall yield from 1, after chromatography. Acid hydrolysis of the ketal with 10% aqueous acetic acid 18 provided [5'-2 H]-uridine 4 in 61% yield after crystallization. The 'H NMR spectrum of 4 showed the level of deuterium incorporation to be approximately 90% from integration of the residual H5' resonances, with a 1:1 mixture of the H5'R and H5'S diastereoisomers. The upfield resonance was assigned to H5'R based on earlier work by Kline and Serianni 22 ' 23 . Deuteration of the C5' atom led to small upfield shifts (-0.02 ppm) of both the H5'R and H5'S signals.
[5'-2 H]-Uridine 4 was converted to the protected phosphoramidite 7 in three steps. The 5'-dimethoxytrityl derivative 5 was prepared in 86% yield by treatment of 4 with dimethoxytrityl chloride (1 eq.) in pyridine 19 . The 2' hydroxyl group of 5 was preferentially silylated with t-butyldimethylsilyl chloride in the presence of silver nitrate/pyridine 14 to provide 6 which was separated from the 3'-silyl isomer by silica gel chromatography. The 2'-silyl isomer 6 was converted to the phosphoramidite 7 in quantitative yield 15 and was used in RNA synthesis as a mixture of diastereoisomers. The identity of each deuterium-labelled intermediate was verified by comparison with the corresponding unlabelled compound using thin layer chromatography and 'H NMR. 
RNA synthesis and purification
The chemical synthesis of RNA is more difficult than DNA synthesis due to the requirement for a t-butyldimethylsilyl protecting group on the 2'-hydroxyl functionality 14 -21 which slows the rate of phosphoramidite coupling. In addition, deprotection requires relatively mild conditions. Recent work by Ogilvie and coworkers 14 showed that use of N-phenoxyacetyl phosphoramidites allowed complete deprotection of base and phosphate groups with anhydrous methanolic ammonia at room temperature. These relatively mild conditions minimize hydrolysis of the 2'-silyl group and the concomitant generation of chain cleavage products which can occur when using the more severe conditions necessary for debenzoylation (NHjOH/EtOH, 3/1, v/v, 55°C, 24 h). Indeed, initial trial synthesis of unlabelled [r(CGCGAAUUCGCG)] 2 using N-benzoyl phosphoramidites resulted in 10-20% lower yields and more 'failure' sequences than when using N-phenoxyacetyl phosphoramidites. To obtain sufficient quantities for solid-state deuterium NMR studies, 3x10 micromole syntheses of [r(CGCGAAU*U*CGCG)] 2 (U* = [5'-2 H]U) were carried out. The average coupling yield per cycle was about 97% based on trityl analysis. Phenoxyacetyl and cyanoethyl groups were removed with methanolic ammonia and the 2'-t-butyldimethylsilyl groups were cleaved with tetrabutylammonium fluoride as described in Materials and Methods. Residual tetrabutylammonium salts were removed by cation exchange chromatography.
The crude RNA was purified by HPLC on a reverse phase PRP-1 column at 60°C using an acetonitrile/trimethylammonium acetate buffer system. These columns use a polystyrene/divinylbenzene resin which is more stable to continuous heating than the C-18 reverse phase support and, in our hands, gave superior recovery of purified RNA. The HPLC trace of crude [r(CGCGAAU*U*CGCG)]2 is shown in Figure l(a) with an analytical trace of the purified dodecamer in Figure l(b) . Column heating was necessary to avoid the aggregation problems previously reported 15 as well as competing secondary structures such as duplex and hairpin forms. The use of a volatile buffer system obviated the need for extensive desalting procedures. In particular, the fnmef/iy/amrnoru'um salt was considerably easier to remove by lyophilization than the more commonly used triethylammonium acetate buffer. Purified samples were passed through a short column of Chelex to remove trace metal contaminants, presumably leached from the HPLC apparatus and evidenced by broad (-20 Hz) NMR signals. The'H NMR spectrum after Chelex treatment (Figure 2 ) was consistent with the previously reported spectrum of the unlabelled dodecamer 15 and indicated a sufficiently high level of purity (>95%) for both solution and solid-state NMR analysis. The overall yield of purified [r(CGCGAAU*U*CGCG)] 2 from 3x10 micromole syntheses was 44 mg (39%). This represents an improvement over the 13% recovery recently reported for tritylated AGCU 16 and provides the purified labelled dodecamer in the quantities necessary for solid-state deuterium NMR analysis. We have extended the HPLC purification procedure to a number of other oligoribonucleotides such as r(CAGAUCUG-AGC) and r(GAGCCUGGGAGCUQ with similar recoveries of purified RNA. Figure 3 shows the analytical scale HPLC traces of crude RNA for these sequences and Figure 4 shows the 'H NMR spectrum of purified r(GAGCCUGGGAGCUC) which forms the hairpin found in HTV-TAR under the solution conditions used. High resolution NMR studies of these sequences are currently in progress.
SUMMARY
These results show that oligoribonucleotides with site-specific deuterium labels can be synthesized and purified in a reasonably efficient manner to provide the multi-milligram quantities required for solid-state deuterium NMR analysis. Such studies will be important in providing a greater understanding of RNA structure and dynamics. We believe that the HPLC procedure described above will be generally applicable to the purification of other oligoribonucleotide sequences and will assist biophysical studies, such as solution and solid-state NMR, which require relatively large quantities of RNA oligomers.
